You have 9 free searches left this month | for more free features.

City

Ann Arbor (1)

Badalona (1)

Caceres (1)

Cincinnati (1)

Columbus (1)

Houston (1)

Suzhou (1)

Valencia (1)

Condition

AML/MDS (1)

Acute Myeloid Leukemia (1)

CMML (1)

Chronic Myelomonocytic Leukemia (1)

Myelodysplastic Syndromes (1)

Refractory Acute Lymphoblastic Leukemia (1)

Relapse (1)

Relapse Leukemia (1)

Relapsed Adult AML (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD. (1)

Newave Pharmaceutical Inc (1)

Collaborator

Intervention

lp-108 (2)

azacitidine (1)

lp-108 and azacitidine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

lp-108

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting

Acute Myeloid Leukemia
+2 more

LP-108
Azacitidine

(no location specified)

Nov 29, 2022

AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

Recruiting

AML/MDS
+5 more

LP-108
LP-108 and azacitidine

Ann Arbor, Michigan
+7 more

Feb 14, 2022